Chemours (CC) Price Target Lifted by Mizuho Amid Higher Market Multiples

The Chemours Company (NYSE:CC) ranks among the best specialty chemicals stocks to invest in. Mizuho maintained its Outperform rating on The Chemours Company (NYSE:CC) and raised its price target from $16 to $19 on September 23. The increase is mostly attributable to higher market multiples, as Mizuho used a higher multiple of roughly 6.5x next-twelve-months EBITDA instead of the previous 6.0x multiple.

With the impending DuPont split, Qnity’s recent bond offering, and rumors of a possible Corteva split, Mizuho pointed out that concerns over shared PFAS liabilities have been growing.

The firm further noted that The Chemours Company (NYSE:CC) is not trading as if PFAS tail risk is likely, which is consistent with the firm’s own opinion that, unless Chemours goes bankrupt, there seems to be little lingering liability.

The Chemours Company (NYSE:CC) manufactures industrial and specialty products for a variety of industries, including coating, plastics, semiconductors, transportation, oil and gas, refrigeration and air conditioning, among others.

While we acknowledge the potential of CC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.